Anti-tumor Effect of Oleic Acid in Hepatocellular Carcinoma Cell Lines

autophagy cancer cell death fatty acids lipid droplets

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2021
Historique:
received: 13 11 2020
accepted: 14 01 2021
entrez: 22 2 2021
pubmed: 23 2 2021
medline: 23 2 2021
Statut: epublish

Résumé

Oleic acid (OA) is a component of the olive oil. Beneficial health effects of olive oil are well-known, such as protection against liver steatosis and against some cancer types. In the present study, we focused on OA effects in hepatocellular carcinoma (HCC), investigating responses to OA treatment (50-300 μM) in HCC cell lines (Hep3B and Huh7.5) and in a healthy liver-derived human cell line (THLE-2). Upon OA administration higher lipid accumulation, perilipin-2 increase, and autophagy reduction were observed in HCC cells as compared to healthy cells. OA in the presence of 10% FBS significantly reduced viability of HCC cell lines at 300 μM through Alamar Blue staining evaluation, and reduced cyclin D1 expression in a dose-dependent manner while it was ineffective on healthy hepatocytes. Furthermore, OA increased cell death by about 30%, inducing apoptosis and necrosis in HCC cells but not in healthy hepatocytes at 300 μM dosage. Moreover, OA induced senescence in Hep3B, reduced P-ERK in both HCC cell lines and significantly inhibited the antiapoptotic proteins c-Flip and Bcl-2 in HCC cells but not in healthy hepatocytes. All these results led us to conclude that different cell death processes occur in these two HCC cell lines upon OA treatment. Furthermore, 300 μM OA significantly reduced the migration and invasion of both HCC cell lines, while it has no effects on healthy cells. Finally, we investigated autophagy role in OA-dependent effects by using the autophagy inducer torin-1. Combined OA/torin-1 treatment reduced lipid accumulation and cell death as compared to single OA treatment. We therefore concluded that OA effects in HCC cells lines are, at least, in part dependent on OA-induced autophagy reduction. In conclusion, we report for the first time an autophagy dependent relevant anti-cancer effect of OA in human hepatocellular carcinoma cell lines.

Identifiants

pubmed: 33614661
doi: 10.3389/fcell.2021.629182
pmc: PMC7892977
doi:

Types de publication

Journal Article

Langues

eng

Pagination

629182

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Giulitti, Petrungaro, Mandatori, Tomaipitinca, de Franchis, D'Amore, Filippini, Gaudio, Ziparo and Giampietri.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nature. 2004 Nov 18;432(7015):316-23
pubmed: 15549093
Nature. 2009 Apr 30;458(7242):1131-5
pubmed: 19339967
Biosci Biotechnol Biochem. 2014;78(12):2022-9
pubmed: 25198914
Clin Cancer Res. 2011 Oct 1;17(19):6229-38
pubmed: 21825039
Autophagy. 2017 Jul 3;13(7):1130-1144
pubmed: 28548876
Sci Rep. 2017 Sep 12;7(1):11277
pubmed: 28900281
Int Immunopharmacol. 2018 Jun;59:197-208
pubmed: 29656210
Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5123-7
pubmed: 7685115
J Carcinog Mutagen. 2013;Suppl 6:
pubmed: 25379355
Int J Cell Biol. 2014;2014:490275
pubmed: 24587805
Expert Rev Gastroenterol Hepatol. 2011 Apr;5(2):159-66
pubmed: 21476911
Curr Pharm Des. 2011;17(8):769-77
pubmed: 21443484
J Hepatol. 2020 Feb;72(2):215-229
pubmed: 31954487
Cardiovasc Diabetol. 2015 Jun 10;14:75
pubmed: 26055507
JMIR Cancer. 2020 May 19;6(1):e16974
pubmed: 32209538
Carcinogenesis. 2013 Jun;34(6):1343-51
pubmed: 23430956
Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3077-82
pubmed: 12629214
Cancer Lett. 2002 Jan 10;175(1):27-38
pubmed: 11734333
J Hepatol. 2009 Jun;50(6):1132-41
pubmed: 19398230
Cell Death Differ. 2016 Jul;23(7):1099-109
pubmed: 26967968
Diabetologia. 2011 Apr;54(4):954-64
pubmed: 21240477
Cytotechnology. 2015 Jan;67(1):1-12
pubmed: 25002206
J Proteome Res. 2010 Jan;9(1):6-21
pubmed: 19678649
FEBS Lett. 2006 Nov 13;580(26):6109-14
pubmed: 17056040
Mol Nutr Food Res. 2020 Oct;64(20):e2000816
pubmed: 32918380
IUBMB Life. 2019 Jul;71(7):863-872
pubmed: 30707786
Oncotarget. 2015 Nov 17;6(36):38719-36
pubmed: 26451612
Cell Cycle. 2015;14(3):297-304
pubmed: 25564883
Molecules. 2018 Aug 03;23(8):
pubmed: 30081476
Genes Dev. 2007 Nov 15;21(22):2861-73
pubmed: 18006683
Leukemia. 1997 Apr;11 Suppl 3:380-2
pubmed: 9209397
Oncotarget. 2017 Jun 20;8(25):40019-40036
pubmed: 28402954
Biochim Biophys Acta. 2013 Nov;1828(11):2691-9
pubmed: 23916586
Int J Mol Sci. 2017 Jun 15;18(6):
pubmed: 28617309
Nutr Metab (Lond). 2020 Jan 30;17:11
pubmed: 32021639
Genes Cells. 2003 Feb;8(2):131-44
pubmed: 12581156
Autophagy. 2016;12(1):1-222
pubmed: 26799652
Nutr Hosp. 2012 Nov-Dec;27(6):1860-5
pubmed: 23588432
Biochem Biophys Res Commun. 2019 Jun 18;514(1):92-97
pubmed: 31023527
Cell Death Dis. 2018 Jan 24;9(2):90
pubmed: 29367738
Mini Rev Med Chem. 2013 Feb;13(2):201-10
pubmed: 23278117
Hepatology. 2010 Apr;51(4):1218-25
pubmed: 20112426
J Cell Sci. 2014 Jul 15;127(Pt 14):3104-15
pubmed: 24876224
Exp Mol Med. 2018 Aug 3;50(8):93
pubmed: 30076294
Nutrients. 2019 Apr 11;11(4):
pubmed: 30979078
Nat Commun. 2020 Aug 13;11(1):4056
pubmed: 32792483
Sci Rep. 2019 Dec 20;9(1):19593
pubmed: 31863022
Am J Transl Res. 2011 May 15;3(3):284-91
pubmed: 21654881
Nutr Res Pract. 2020 Dec;14(6):568-579
pubmed: 33282120
Biol Pharm Bull. 2006 Nov;29(11):2174-80
pubmed: 17077510
Biochem Biophys Res Commun. 2018 Oct 7;504(3):582-589
pubmed: 29438712
Genes (Basel). 2010 Nov 18;1(3):413-26
pubmed: 24710095
World J Gastroenterol. 2009 Apr 21;15(15):1809-15
pubmed: 19370776
Cell Death Differ. 2012 Jan;19(1):87-95
pubmed: 22052193
Yale J Biol Med. 2019 Sep 20;92(3):435-452
pubmed: 31543707
Biochim Biophys Acta. 2013 Jun;1834(6):1125-43
pubmed: 23499846
PLoS One. 2014 May 13;9(5):e97330
pubmed: 24823908
Cell Cycle. 2015;14(11):1631-42
pubmed: 25927598
Oxid Med Cell Longev. 2018 Dec 2;2018:1471682
pubmed: 30622661

Auteurs

Federico Giulitti (F)

Department of Anatomical, Histological, Forensic Medicine, and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.

Simonetta Petrungaro (S)

Department of Anatomical, Histological, Forensic Medicine, and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.

Sara Mandatori (S)

Department of Anatomical, Histological, Forensic Medicine, and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.

Luana Tomaipitinca (L)

Department of Anatomical, Histological, Forensic Medicine, and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.

Valerio de Franchis (V)

Department of Anatomical, Histological, Forensic Medicine, and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.

Antonella D'Amore (A)

Department of Anatomical, Histological, Forensic Medicine, and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.

Antonio Filippini (A)

Department of Anatomical, Histological, Forensic Medicine, and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.

Eugenio Gaudio (E)

Department of Anatomical, Histological, Forensic Medicine, and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.

Elio Ziparo (E)

Department of Anatomical, Histological, Forensic Medicine, and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.

Claudia Giampietri (C)

Department of Anatomical, Histological, Forensic Medicine, and Orthopedic Sciences, Sapienza University of Rome, Rome, Italy.

Classifications MeSH